RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
| Autor: | Hans Gelderblom, Els L. van Persijn van Meerten, Johan L. Bloem |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: |
Target lesion
Diagnostic Imaging medicine.medical_specialty Internationality Antineoplastic Agents Review Guidelines Neoplasms medicine Medical imaging Humans Radiology Nuclear Medicine and imaging Neuroradiology medicine.diagnostic_test business.industry Antitumour drugs Interventional radiology Drug evaluation General Medicine Guideline medicine.disease Review article Oncology RECIST Radiology Nuclear Medicine and imaging Hepatocellular carcinoma Practice Guidelines as Topic Radiology business Progressive disease |
| Zdroj: | European Radiology |
| ISSN: | 1432-1084 0938-7994 |
| Popis: | The purpose of this review article is to familiarize radiologists with the recently revised Response Evaluation Criteria in Solid Tumours (RECIST), used in many anticancer drug trials to assess response and progression rate. The most important modifications are: a reduction in the maximum number of target lesions from ten to five, with a maximum of two per organ, with a longest diameter of at least 10 mm; in lymph nodes (LNs) the short axis rather than the long axis should be measured, with normal LN measuring |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink